Explore
Trendline
Johnson Johnson Appoints Tom Cavanaugh Amidst Strategic Pharmaceutical Transition
Johnson Johnson Appoints Tom Cavanaugh Amidst Strategic Pharmaceutical Transition
Read More
Trendline
Pfizer's Quarterly Earnings Surpass Expectations Amid Decline in COVID-19 Product Sales
Pfizer's Quarterly Earnings Surpass Expectations Amid Decline in COVID-19 Product Sales
Read More
Trendline
Eli Lilly Increases Price Target Following Strong GLP-1 Drug Sales
Eli Lilly Increases Price Target Following Strong GLP-1 Drug Sales
Read More
Trendline
Welltower Faces 8.1% Stock Decline Amidst Market Growth
Welltower Faces 8.1% Stock Decline Amidst Market Growth
Read More
Trendline
China's Biopharma Ecosystem Reshapes Global Drug Development Landscape
China's Biopharma Ecosystem Reshapes Global Drug Development Landscape
Read More
Trendline
Novo Nordisk Shares Decline After Disappointing Guidance
Novo Nordisk Shares Decline After Disappointing Guidance
Read More
Trendline
Novo Nordisk Reports Mixed Results in Phase 3 Trial for Cardiovascular Drug Ziltivekimab
Novo Nordisk Reports Mixed Results in Phase 3 Trial for Cardiovascular Drug Ziltivekimab
Read More
Trendline
Merck Reports Q2 2026 Financial Results Amid Key Product Launches
Merck Reports Q2 2026 Financial Results Amid Key Product Launches
Read More
Trendline
Pfizer Adjusts 2026 Revenue Guidance Amid Decline in Covid-19 Sales
Pfizer Adjusts 2026 Revenue Guidance Amid Decline in Covid-19 Sales
Read More
Trendline
Gilead Sciences Reports Strong Revenue Growth Despite Losses in Q2 2026
Gilead Sciences Reports Strong Revenue Growth Despite Losses in Q2 2026
Read More
Trendline
Eli Lilly Exceeds Q2 2026 Earnings Expectations with Strong Drug Sales
Eli Lilly Exceeds Q2 2026 Earnings Expectations with Strong Drug Sales
Read More
Trendline
Novo Nordisk Raises 2026 Forecasts Amid Strong GLP-1 Sales
Novo Nordisk Raises 2026 Forecasts Amid Strong GLP-1 Sales
Read More
